World's Best Scientists 2026 revealed!
Vincent C. Marconi

Vincent C. Marconi

D-Index & Metrics

Immunology

D-Index
57
Citations
18771
World Ranking
3581
National Ranking
1659

Overview

Vincent C. Marconi is affiliated with Emory University in the United States. Their research primarily spans the field of Medicine, with a focus on Infectious Diseases, Emergency Medicine, Epidemiology, Virology, and General Health Professions.

Their recent work has concentrated on topics related to HIV/AIDS research and interventions, HIV-related health complications and treatments, HIV research and treatment, COVID-19 clinical research studies, HIV/AIDS drug development and treatment, long-term effects of COVID-19, and SARS-CoV-2 and COVID-19 research.

Frequent coauthors collaborating with Vincent C. Marconi include:

  • Amy C. Justice
  • Richard D. Moore
  • Michael J. Silverberg
  • Keri N. Althoff
  • Michael A. Horberg

The scientist's publications often appear in these venues:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • UNC Libraries
  • Open Forum Infectious Diseases
  • AIDS

Selected recent papers authored or coauthored by Vincent C. Marconi include:

  • "Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19" (2020), published in New England Journal of Medicine
  • "The potential use of digital health technologies in the African context: a systematic review of evidence from Ethiopia" (2021), published in npj Digital Medicine
  • "Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019" (2020), published in Clinical Infectious Diseases
  • "Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial" (2022), published in The Lancet Respiratory Medicine
  • "Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalization - Five Veterans Affairs Medical Centers, United States, February 1-August 6, 2021" (2021), published in MMWR Morbidity and Mortality Weekly Report

Best Publications

  • Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.

    Andre C Kalil;Thomas F Patterson;Aneesh K Mehta;Kay M Tomashek

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

    Pereyra F;Jia X;McLaren Pj

  • Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long-Term Nonprogressors in the US Department of Defense HIV Natural History Study

    Jason F. Okulicz;Jason F. Okulicz;Vincent C. Marconi;Vincent C. Marconi;Michael L. Landrum;Michael L. Landrum;Scott Wegner

  • Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: A 20-year cohort study

    Nancy Crum-Cianflone;Katherine Huppler Hullsiek;Vincent Marconi;Vincent Marconi;Amy Weintrob;Amy Weintrob

  • HIV treatment adherence, drug resistance, virologic failure: evolving concepts.

    Jean B. Nachega;Vincent C. Marconi;Gert U. van Zyl;Edward M. Gardner

  • Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa.

    Vincent C. Marconi;Henry Sunpath;Zhigang Lu;Michelle Gordon

  • Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

    John Gregson;Michele Tang;Nicaise Ndembi;Raph L Hamers

  • Increasing rates of obesity among HIV-infected persons during the HIV epidemic

    Nancy Crum-Cianflone;Nancy Crum-Cianflone;Nancy Crum-Cianflone;Mollie Poehlman Roediger;Mollie Poehlman Roediger;Lynn Eberly;Lynn Eberly;Maryam Headd

  • Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE ε4/ε4 genotype accelerates HIV disease progression

    Trevor D. Burt;Brian K. Agan;Vincent C. Marconi;Weijing He

  • CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms.

    Matthew J. Dolan;Hemant Kulkarni;Jose F. Camargo;Weijing He

  • Anal cancers among HIV-infected persons: HAART is not slowing rising incidence.

    Nancy F. Crum-Cianflone;Nancy F. Crum-Cianflone;Katherine Huppler Hullsiek;Vincent C. Marconi;Vincent C. Marconi;Anuradha Ganesan;Anuradha Ganesan

  • Duffy Antigen Receptor for Chemokines Mediates trans-Infection of HIV-1 from Red Blood Cells to Target Cells and Affects HIV-AIDS Susceptibility

    Weijing He;Stuart Neil;Hemant Kulkarni;Hemant Kulkarni;Edward Wright

  • The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States

    Colleen S. Kraft;Angela L. Hewlett;Scott Koepsell;Anne M. Winkler

  • HIV Infection and Incidence of Cardiovascular Diseases: An Analysis of a Large Healthcare Database

    Alvaro Alonso;A. Elise Barnes;Jodie L. Guest;Amit Shah

  • Microvascular Disease, Peripheral Artery Disease, and Amputation

    Joshua A. Beckman;Meredith S. Duncan;Scott M. Damrauer;Scott M. Damrauer;Quinn S. Wells

  • CTLA-4+PD-1− Memory CD4+ T Cells Critically Contribute to Viral Persistence in Antiretroviral Therapy-Suppressed, SIV-Infected Rhesus Macaques

    Colleen S. McGary;Claire Deleage;Justin Harper;Luca Micci

  • Updates of lifetime costs of care and quality-of-life estimates for HIV-infected persons in the United States: late versus early diagnosis and entry into care

    Paul G Farnham;Chaitra Gopalappa;Stephanie L Sansom;Angela B Hutchinson

  • Outbreak of Severe Respiratory Disease Associated with Emergent Human Adenovirus Serotype 14 at a US Air Force Training Facility in 2007

    Jacqueline E. Tate;Michel L. Bunning;Lisa Lott;Xiaoyan Lu

  • CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals.

    Sunil K Ahuja;Hemant Kulkarni;Hemant Kulkarni;Gabriel Catano;Gabriel Catano;Brian K Agan

  • Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019.

    Boghuma K Titanji;Monica M Farley;Monica M Farley;Ashish Mehta;Ashish Mehta;Randi Connor-Schuler

  • Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States

    Allison M. Liddell;Richard T. Davey;Aneesh K. Mehta;Jay B. Varkey

Frequent Co-Authors

Brian K. Agan
Brian K. Agan Uniformed Services University of the Health Sciences
Amy C. Weintrob
Amy C. Weintrob George Washington University
Nancy F. Crum-Cianflone
Nancy F. Crum-Cianflone Naval Medical Center San Diego
Amy C. Justice
Amy C. Justice Yale University
Maria C. Rodriguez-Barradas
Maria C. Rodriguez-Barradas Baylor College of Medicine
David Rimland
David Rimland Emory University
Sunil K. Ahuja
Sunil K. Ahuja The University of Texas Health Science Center at San Antonio
Matthew J. Dolan
Matthew J. Dolan San Antonio Military Medical Center
Daniel R. Kuritzkes
Daniel R. Kuritzkes Brigham and Women's Hospital
Nathan B. Hansen
Nathan B. Hansen University of Georgia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related online degrees such as a Psychiatric Mental Health Nurse Practitioner (PMHNP) can offer valuable clinical experience and career growth. Finding pmhnp programs online with best clinical placement ensures students gain hands-on training crucial for advanced practice roles.

Cost-efficiency is another important factor. If budget is a concern, exploring cheapest pmhnp programs can help prospective students access quality education without excessive financial burden.

Career-wise, understanding how much do dnp nurses make can guide decision-making regarding specialization and location choices. Salaries vary by state and specialty, providing motivation to tailor one’s career pathway strategically.

For those already in nursing, transitioning from a Family Nurse Practitioner (FNP) to an Acute Care Nurse Practitioner (ACNP) is a notable pathway that aligns with immunology-focused intensive care roles. Learning fnp to acnp steps can open advanced clinical opportunities.

Best Scientists Citing Vincent C. Marconi

Trending Scientists